| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A closer look at the effects of postoperative radiotherapy by stage and nodal status: Updated results of an individual participant data meta-analysis in non-small-cell lung cancer
|
Burdett, Sarah
|
|
2013
|
80 |
3 |
p. 350-352
3 p.
|
artikel
|
| 2 |
ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer
|
Preusser, Matthias
|
|
2013
|
80 |
3 |
p. 278-283
6 p.
|
artikel
|
| 3 |
A rare case of squamous cell carcinoma of the lung harbouring ALK and BRAF activating mutations
|
Alrifai, Doraid
|
|
2013
|
80 |
3 |
p. 339-340
2 p.
|
artikel
|
| 4 |
Clinical application of immunocytochemical detection of ALK rearrangement on cytology slides for detection or screening of lung adenocarcinoma
|
Tanaka, Hisashi
|
|
2013
|
80 |
3 |
p. 289-292
4 p.
|
artikel
|
| 5 |
CNS metastases in non-small-cell lung cancer: Current role of EGFR-TKI therapy and future perspectives
|
Berger, Lars Arne
|
|
2013
|
80 |
3 |
p. 242-248
7 p.
|
artikel
|
| 6 |
Coffee consumption and the risk of cancer development
|
Kapoor, Shailendra
|
|
2013
|
80 |
3 |
p. 350-
1 p.
|
artikel
|
| 7 |
Contents
|
|
|
2013
|
80 |
3 |
p. v-vi
nvt p.
|
artikel
|
| 8 |
Delivery optimization of erlotinib according to toxicity: May clinical practice go beyond research?
|
Passaro, Antonio
|
|
2013
|
80 |
3 |
p. 352-353
2 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2013
|
80 |
3 |
p. iii-
1 p.
|
artikel
|
| 10 |
Efficacy of two fluorescence in situ hybridization (FISH) probes for diagnosing malignant pleural effusions
|
Rosolen, Débora C.B.
|
|
2013
|
80 |
3 |
p. 284-288
5 p.
|
artikel
|
| 11 |
EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: A case–control study of overall survival
|
Faehling, M.
|
|
2013
|
80 |
3 |
p. 306-312
7 p.
|
artikel
|
| 12 |
Impact of renal function on treatment options and outcomes in advanced non-small cell lung cancer
|
Kutluk Cenik, Bercin
|
|
2013
|
80 |
3 |
p. 326-332
7 p.
|
artikel
|
| 13 |
K-ras 4A and 4B mRNA levels correlate with superoxide in lung adenocarcinoma cells, while at the protein level, only mutant K-ras 4A protein correlates with superoxide
|
Calvert, Richard J.
|
|
2013
|
80 |
3 |
p. 263-269
7 p.
|
artikel
|
| 14 |
Pemetrexed-induced neutropenic enteritis and severe cutaneous hyperpigmentation in a patient with malignant pleural mesothelioma
|
Buchinger, Katharina
|
|
2013
|
80 |
3 |
p. 347-349
3 p.
|
artikel
|
| 15 |
Personalized therapy on the horizon for squamous cell carcinoma of the lung
|
Kim, Han Sang
|
|
2013
|
80 |
3 |
p. 249-255
7 p.
|
artikel
|
| 16 |
Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer
|
Lim, Seungtaek
|
|
2013
|
80 |
3 |
p. 313-318
6 p.
|
artikel
|
| 17 |
Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancer
|
Heigener, David F.
|
|
2013
|
80 |
3 |
p. 319-325
7 p.
|
artikel
|
| 18 |
Radiofrequency ablation for non-small-cell lung cancer in a single-lung patient: Case report and review of the literature
|
Modesto, A.
|
|
2013
|
80 |
3 |
p. 341-343
3 p.
|
artikel
|
| 19 |
Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?
|
Hendriks, Lizza E.L.
|
|
2013
|
80 |
3 |
p. 293-297
5 p.
|
artikel
|
| 20 |
Successful treatment with erlotinib of severe neutropenia induced by gefitinib in a patient with advanced non-small cell lung cancer
|
Araya, Tomoyuki
|
|
2013
|
80 |
3 |
p. 344-346
3 p.
|
artikel
|
| 21 |
The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: Long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801
|
Lawrence, Yaacov Richard
|
|
2013
|
80 |
3 |
p. 298-305
8 p.
|
artikel
|
| 22 |
Tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone suppresses a newly identified anti-tumor IGFBP-3/IGFBP-3R system in lung cancer cells
|
Harada, Aki
|
|
2013
|
80 |
3 |
p. 270-277
8 p.
|
artikel
|
| 23 |
Tumor-associated macrophages in thoracic malignancies
|
Lievense, L.A.
|
|
2013
|
80 |
3 |
p. 256-262
7 p.
|
artikel
|
| 24 |
Uncommon Epidermal Growth Factor Receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistance
|
Massarelli, Erminia
|
|
2013
|
80 |
3 |
p. 235-241
7 p.
|
artikel
|
| 25 |
XBP1 promoter polymorphism modulates platinum-based chemotherapy gastrointestinal toxicity for advanced non-small cell lung cancer patients
|
Peng, J.
|
|
2013
|
80 |
3 |
p. 333-338
6 p.
|
artikel
|
Tijdschrift beschrijving